Article
Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer
11 Apr 2022
Abstract excerpt
BACKGROUND: Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDA), is an aggressive malignancy associated with a low 5-year survival rate. Poor outcomes associated with PDA are attributable to late detection and inoperability. Most patients with PDA are diagnosed with locally advanced and metastatic disease. Such cases are primarily treated with chemotherapy and radiotherapy. Because of the lack...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
